Cytokinetics Inc - Company Profile
Powered by 
All the sales intelligence you need on Cytokinetics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Cytokinetics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Cytokinetics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Cytokinetics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Cytokinetics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
John T. Henderson
Chairman Executive BoardDr. John T. Henderson has been Chairman of the company since 2022. Prior to this, he served as a Consultant to the pharmaceutical industry. Dr. Henderson has also served as a Vice President in the Pfizer Pharmaceuticals Group, Pfizer Inc; Vice President, Research & Development in Europe, and later Japan; and as Vice President of Medical for Pfizer’s Europe, US; and International Pharmaceuticals groups.
Robert I. Blum
Chief Executive Officer; President; Director Executive BoardMr. Robert I. Blum has been the President, Chief Executive Officer and Director of the company since January 2007. Prior to this role, he served as the company’s President and and held other senior-level positions at the company in research and development, finance, business development, corporate development, legal and commercial operations.
Sung H. Lee
Executive Vice President; Chief Financial Officer Senior ManagementMr. Sung H. Lee has been the Chief Financial Officer and Executive Vice President of the company since 2024. Prior to this, he served as Chief Financial Officer at Vir Biotechnology, Inc. Previously, he served as the Executive Vice President and Chief Financial Officer at Sangamo Therapeutics, Inc.
Kari K. Loeser
Chief Compliance Officer; Vice President Senior ManagementMs. Kari K. Loeser has been the Vice President and Chief Compliance Officer of the company since 2021. Prior to this, she served as the US Healthcare Compliance and Privacy Officer and Senior Corporate Counsel at Vifor Pharma Inc. Previously, Ms. Loeser served as Senior Director and Senior Compliance Counsel at Jazz Pharmaceuticals.
Stuart Kupfer, M.D.
Chief Medical Officer; Senior Vice President Senior ManagementDr. Stuart Kupfer has been the Chief Medical Officer and Senior Vice President of the company since 2020. Prior to this, he served as Vice President and Therapeutic Area Head of Cardiometabolic Clinical Development, Takeda and in Clinical Research at Abbott and Searle/Pharmacia.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer